Walleye Capital’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Buy
+20,600
New +$126K ﹤0.01% 3394
2026
Q1
Sell
-86,200
Closed -$838K 4889
2025
Q4
$838K Buy
86,200
+26,000
+43% +$221K ﹤0.01% 2583
2025
Q3
$252K Buy
+60,200
New +$385K ﹤0.01% 3149
2024
Q2
Sell
-3,000
Closed -$24.5K 5934
2024
Q1
$24.5K Sell
3,000
-7,700
-72% -$63.1K ﹤0.01% 4875
2023
Q4
$90.2K Buy
+10,700
New +$124K ﹤0.01% 4091

Other funds holding REPL

Walleye Capital's REPL Position: Q2 2026 in Review

Walleye Capital reduced its Replimune Group (REPL) stake by 96% in Q2 2026, selling an estimated $421K and leaving 2,729 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4320.

Walleye Capital first reported a position in REPL in Q2 2023 and has held it in 7 quarters since. The position peaked at $1.18M in Q2 2023. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Walleye Capital held 2,729 shares of Replimune Group worth $30.2K as of Q2 2026.
  • Walleye Capital sold 68,863 Replimune Group shares in Q2 2026, an estimated $421K.
  • Replimune Group made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4320 holding.
  • Walleye Capital first reported a position in Replimune Group in Q2 2023 and has held it in 7 quarters since.
  • Walleye Capital's Replimune Group position peaked at $1.18M in Q2 2023.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.